- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06919263
Influencer E-Cigarette and Cannabis Marketing: a Survey-Based Experiment Among Adolescents
Adolescent non-users of e-cigarettes and cannabis (N = 1,462) participated in the in-class survey-based experiment. They were randomly shown 3 pairs of images featuring influencers promoting e-cigarettes alongside cannabis, (experimental group), or no-substance use or display (placebo treatment), or e-cigarette promotion alone (control). After viewing each pair of images, participants rated perceptions of influencer credibility (i.e., honesty, trustworthiness, knowledge) on the scale of 0 (e.g., dishonest) to 100 (honest).
Susceptibility to use e-cigarettes was assessed after participants viewed all the images. These outcomes were then compared among participants who perceived influencers as credible and those who perceived influencers as non-credible.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90032
- University of Southern California
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- English fluency,
- Current California resident.
Exclusion Criteria:
Not meeting these criteria:
- English fluency,
- Current California resident.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Experimental group
Images featuring influencers promoting e-cigarettes alongside cannabis
|
Participants viewed survey-imbedded promotional images featuring influencers
|
|
Active Comparator: Placebo group
Images featuring neutral profiles of influencers not using or displaying any substances
|
Participants viewed survey-imbedded promotional images featuring influencers
|
|
Active Comparator: Control
Images featuring influencers promoting e-cigarettes alone
|
Participants viewed survey-imbedded promotional images featuring influencers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceptions of influencer credibility
Time Frame: assessed during the ~ 30-minute experiment, immediately after each of the three pairs of influencer images
|
Perceptions of influencer credibility (i.e., honesty, trustworthiness, knowledge) were assessed using a 0 (e.g., dishonest) -100 (e.g., honest) scale that has been validated in prior research.
|
assessed during the ~ 30-minute experiment, immediately after each of the three pairs of influencer images
|
|
Susceptibility to use e-cigarettes
Time Frame: one-time assessment after the experimental exposure (immediately post-treatment)
|
Susceptibility to use e-cigarettes was measured using the validated three-item scale adapted from Population Assessment of Tobacco and Health (PATH), and combined into one variable (α=0.93).
Consistent with prior research, the measure was dichotomized with responses "definitely not" to all items being coded as "not susceptible" and responses "probably not," "probably yes", or "definitely yes" being coded as "susceptible."
|
one-time assessment after the experimental exposure (immediately post-treatment)
|
Collaborators and Investigators
Investigators
- Study Director: Gina Klemm, University of Southern California
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HS-19-00682-AM016
- T33DT6620 (Other Grant/Funding Number: TRDRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electronic Nicotine Delivery Systems
-
University of Sao PauloNot yet recruitingElectronic Nicotine Delivery SystemsBrazil
-
Peking UniversityChina Medical BoardCompletedRegulation Compliance | Electronic Nicotine Delivery SystemsChina
-
University of ChicagoRecruitingCigarette Smoking | Tobacco Products | Electronic Nicotine Delivery SystemsUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedElectronic Nicotine Delivery System FlavorsUnited States
-
Liverpool School of Tropical MedicineKenya Medical Research Institute; LVCT HealthRecruitingPregnancy | Health Systems | Electronic Community Health Information Systems | Antenatal Clinic UptakeKenya
-
Ostia SciencesNot yet recruiting
-
Duke UniversityOdessey II SolutionsWithdrawnOxygen Delivery Systems at Altitude
-
Instituto de Oftalmología Fundación Conde de ValencianaRecruitingPhoto-aged Skin | Skin Quality Improvement | Drug Delivery SystemsMexico
-
Hannover Medical SchoolCompletedEqually of Delivery Systems of Local Anesthesia in BronchoscopyGermany
-
October 6 UniversityNot yet recruitingSmoking Electronic Cigarettes (Vaping), With Moderate and High Dependence for NicotineEgypt
Clinical Trials on Influencer marketing
-
University of Southern CaliforniaCompleted
-
University of Southern CaliforniaTobacco Related Disease Research ProgramCompleted
-
California State Polytechnic University, PomonaCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
-
Washington University School of MedicineUniversity of Rhode Island; Pwani University; Egerton UniversityActive, not recruitingMalnutrition, Child | Growth; Stunting, NutritionalKenya
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Tufts UniversityCompleted
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | VapingUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Recruiting
-
Washington University School of MedicineKamuzu University of Health Sciences; Project Peanut Butter, MalawiCompletedNutritional StuntingMalawi